US Medical Affairs Leader- Immuno-Oncology

Your Responsibilities:
As a global healthcare company, GSK takes on some of the world's biggest healthcare challenges. The biggest contribution we can make to society is to innovate and widen access to new medicines, vaccines and consumer healthcare products. We continue to be committed to develop medicines to support fighting cancer. Over the last few years our R&D team has been using 'next generation' technology platforms to increase understanding of disease mechanisms, which will help us deliver significant medical advances to cancer patients.

Your role will be at the forefront of GSK's re-emergence in discovering and providing cutting edge Immuno-Oncology treatments. Our leading Oncology asset is GSK2857916/GSK'916, an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. This is a first in class antibody drug conjugate that has a four-fold mechanism of action with evidence of high efficacy in a precisely defined group of Multiple Myeloma patients. BCMA has recently been granted Breakthrough Therapy Designation from the FDA and as such we are looking to launch the asset at speed.


The US Medical Affairs Leader (USMAL) is the single point of medical accountability for a medicine or medicine(s) and leads the development and execution of US Medical Affairs strategies for a medicine(s) including (if applicable) the launch optimization of such medicine(s).
• Aligns and directs all medical affairs resources into a focused vision and strategy
• Provides one medical affairs voice, medical expertise, and insight within the US
• Collaborates with clinical development to provide insights and ensure US needs and issues are addressed
• Incorporates US Medical Affairs voice at the global franchise or business unit level

The overall purpose for this role in the current Medical organization is to enable Medical to be a strategic scientific partner to both internal stakeholders and customers. This position will be able to strategically engage in a credible and ethical manner in understanding how the science and clinical care will evolve and advance in the future, informing scientifically sound and clinically meaningful positioning of GSK or our products and the identification of critical knowledge/evidence gaps at both the product and disease area levels. Key capabilities include strategic thinking, business acumen, effective matrix leadership, with proven ability to motivate, influence, negotiate, and collaborate; strong project management skills; solid planning and organizational skills; strong scientific/analytical problem solving skills.
• In collaboration with the Vice President, Therapy Area Head drives the strategic direction and execution of all medical affairs work for the immune-oncology compounds by leading the US Medical Matrix Team(s) and co-leading the US Medical Commercial Strategy Team(s).
• The role scope includes both internal and external components. Internally, this role will align key business leader insights across R&D and Commercial global and local key stakeholders, include resource alignment with the Medical Engagement team to inform the TA resources and medical strategies. The USMAL will ensure global alignment to evidence generation and commercial strategies. Externally, leads/contributes to appropriate US scientific engagement between GSK field medical and external communities in order to advance scientific and medical understanding including the appropriate development and use of our medicines, the management of disease, and patient care.
• Ensures US customers (payers, HCPs, Policymakers, health systems) are appropriately engaged over the life cycle of the medicine in close collaboration with field medical to meet US reimbursement needs.
• Leads the interpretation, translation and integration of medical voice of customer (patients, providers, payers) into medical affairs strategy and prioritizes patient's benefit and welfare.
• Maintains deep product and disease expertise on the medicine(s) and includes market and competitive knowledge in all medical plans.
• Provides input into the design of Phase IIIB/IV studies and selection of investigator sponsored studies in alignment with the global franchises.

*LI-GSK
Please use the cover letter to highlight how you meet the qualifications and competencies for the role. Your CV along with your cover letter will be used to assess your application.

Why You?

Basic qualifications:
•Scientist with Ph.D., Pharm D or equivalent
• Significant pharmaceutical industry and scientific/medical affairs experience is required.
• Deep clinical and scientific knowledge in hematological malignancy, immuno-oncology, multiple myeloma preferred
• Launch experience is required
• The position will require many internal and external senior leadership interactions; including at external national and regional meetings. Local or Global experience in these types of arenas is considered as an asset.
• Thorough understanding of the US healthcare environment, stakeholders and customers.
• Demonstrated effectiveness for development and execution of medical strategy.
• Excellent communications and leadership skills: able to effectively communicate written and verbal scientific data and to understand the clinical implications of the data.
• Experience in line management and leadership of highly effective and motivated matrix teams.
• Skilled in leveraging available resources to drive business improvement.
• Demonstrated ability of strategic thinking, project management, and leadership/management
• Demonstrated ability to work across boundaries and geographies effectively

Preferred qualifications:
Medical doctor with Board certification/qualification, and clinical experience in oncology or hematology/oncology preferred. Launch experience is required

Why GSK?:
GSK Oncology is one of GSK Pharma's 4 core therapy areas and is considered a future growth driver for the company. In 2014, GSK divested its Oncology late stage development and commercial business (ie targeted therapies such as kinase inhibitors and other traditional anti-cancer agents) to Novartis. However, GSK retained its Oncology discovery/preclinical portfolio (comprised of innovative next generation anti-cancer agents) and infrastructure. Since 2014, GSK has progressed this innovative portfolio and has delivered over 9 novel assets into clinical development (alone or in partnership). Moreover, GSK Oncology has established a strong position and focus in three areas; namely, cancer epigenetics, immune-oncology and combinations, and oncology cell therapies (TCR-T and CAR-T).

The GSK Oncology vision is to maximize the survival of cancer patients by delivering transformational medicines alone or in combination. In addition to in-house discovery and development, the Therapy Area (TA) will rely on outside innovation to deliver this vision. Importantly, Oncology represents one of the most heavily invested and innovative therapy areas across the life sciences and Healthcare industry. The field is evolving at an unprecedented pace and, if leveraged/accessed properly via business development, is expected to contribute to the overall vision of GSK Oncology.

Contact information:
You may apply for this position online by selecting the Apply now button.
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK HR Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).

GSK is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record site.


Back to top